These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nutraceutical Potential of Phenolics from 'Brava' and 'Mansa' Extra-Virgin Olive Oils on the Inhibition of Enzymes Associated to Neurodegenerative Disorders in Comparison with Those of 'Picual' and 'Cornicabra'. Figueiredo-González M; Reboredo-Rodríguez P; González-Barreiro C; Carrasco-Pancorbo A; Simal-Gándara J; Cancho-Grande B Molecules; 2018 Mar; 23(4):. PubMed ID: 29561824 [TBL] [Abstract][Full Text] [Related]
25. Protective Effect of Lemon Peel Extract on Oxidative Stress in H9c2 Rat Heart Cell Injury. Wang J; Zhai Y; Ou M; Bian Y; Tang C; Zhang W; Cheng Y; Li G Drug Des Devel Ther; 2021; 15():2047-2058. PubMed ID: 34017169 [TBL] [Abstract][Full Text] [Related]
26. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease. Nakajima A; Ohizumi Y Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812 [TBL] [Abstract][Full Text] [Related]
27. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review. Manzoor S; Hoda N Eur J Med Chem; 2020 Nov; 206():112787. PubMed ID: 32942081 [TBL] [Abstract][Full Text] [Related]
28. Ajmalicine and Reserpine: Indole Alkaloids as Multi-Target Directed Ligands Towards Factors Implicated in Alzheimer's Disease. Kashyap P; Kalaiselvan V; Kumar R; Kumar S Molecules; 2020 Apr; 25(7):. PubMed ID: 32244635 [TBL] [Abstract][Full Text] [Related]
29. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease. Wang YH; Samoylenko V; Tekwani BL; Khan IA; Miller LS; Chaurasiya ND; Rahman MM; Tripathi LM; Khan SI; Joshi VC; Wigger FT; Muhammad I J Ethnopharmacol; 2010 Apr; 128(3):662-71. PubMed ID: 20219660 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents. Ye C; Xu R; Cao Z; Song Q; Yu G; Shi Y; Liu Z; Liu X; Deng Y Bioorg Chem; 2021 Jun; 111():104895. PubMed ID: 33887586 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site. Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902 [TBL] [Abstract][Full Text] [Related]
32. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study. Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558 [TBL] [Abstract][Full Text] [Related]
33. Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease. Checkoway H; Costa LG; Woods JS; Castoldi AF; Lund BO; Swanson PD J Neural Transm Park Dis Dement Sect; 1992; 4():283-90. PubMed ID: 1388699 [TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. Nagatsu T; Sawada M J Neural Transm Suppl; 2006; (71):53-65. PubMed ID: 17447416 [TBL] [Abstract][Full Text] [Related]
35. Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase. Bester E; Petzer A; Petzer JP Bioorg Chem; 2022 Jun; 123():105791. PubMed ID: 35413582 [TBL] [Abstract][Full Text] [Related]
36. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine. Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of BACE1, MAO-B, cholinesterase enzymes, and anti-amyloidogenic potential of selected natural phytoconstituents: Multi-target-directed ligand approach. Chowdhury S; Kumar S J Food Biochem; 2021 Jan; 45(1):e13571. PubMed ID: 33249607 [TBL] [Abstract][Full Text] [Related]
38. Deep eutectic solvent mediated synthesis of 3,4-dihydropyrimidin-2(1H)-ones and evaluation of biological activities targeting neurodegenerative disorders. Saleem Khan M; Asif Nawaz M; Jalil S; Rashid F; Hameed A; Asari A; Mohamad H; Ur Rehman A; Iftikhar M; Iqbal J; Al-Rashida M Bioorg Chem; 2022 Jan; 118():105457. PubMed ID: 34798458 [TBL] [Abstract][Full Text] [Related]
39. Dual Monoamine Oxidase and Cholinesterase Inhibitors with Different Heterocyclic Scaffolds. Gulcan HO; Orhan IE Curr Top Med Chem; 2021; 21(30):2752-2765. PubMed ID: 34477521 [TBL] [Abstract][Full Text] [Related]
40. The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30. Youdim MB Curr Alzheimer Res; 2006 Dec; 3(5):541-50. PubMed ID: 17168653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]